drugset / Trial / NCT01597388
AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to assess safety and tolerability of AZD2014 when given in combination with Fulvestrant
Timeline
- Start
- 2012-05-08
- Primary completion
- 2016-08-04
- Completion
- 2026-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vistusertib | Small molecule | — | Oral |
| Background | Fulvestrant | Small molecule | — | Intramuscular |